U.S. Markets closed

Microbot Medical Inc. (MBOT)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
4.8500-0.1200 (-2.41%)
At close: 04:00PM EDT
4.9500 +0.10 (+2.06%)
After hours: 07:08PM EDT

Microbot Medical Inc.

25 Recreation Park Drive
Unit 108
Hingham, MA 02043
United States
781 875 3605

IndustryMedical Instruments & Supplies
Full Time Employees20

Key Executives

NameTitlePayExercisedYear Born
Mr. Harel GadotCo-Founder, Pres, CEO & Chairman813.8kN/A1973
Mr. Yoseph BornsteinCO-Founder & Independent Director52.5kN/A1959
Dr. Simon Sharon MBA, MScCTO & GM501.87kN/A1960
Dr. Eyal Morag M.D.Chief Medical Officer & Member of Scientific Advisory Board567.06kN/A1965
Prof. Moshe Shoham D.Sc.Co-Founder, Scientific Director & Chairman of Scientific Advisory BoardN/AN/A1952
Ms. Rachel VakninChief Financial OfficerN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.

Corporate Governance

Microbot Medical Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.